24小时热门版块排行榜    

查看: 1650  |  回复: 6
当前只显示满足指定条件的回帖,点击这里查看本话题的所有回帖

ZCOLE2010

金虫 (初入文坛)

[求助] 投SMJ,他们要求要提交一个 Contributorship Agreement 没弄过求高手指点

最近投SAUDI MEDICAL JOURNAL 杂志,在线投完后 编辑回信说需要填一个Authorship, Contributorship Agreement & Publishing license  。 具体情况如下
Manuscript Number:

       Manuscript Title: Strontium ranelate-loaded chitosan film on titanium surface and its biological effects on osteoblasts


Corresponding Author:   Liang Xing

All authors must read and sign the following statements: (1) Authorship & Contributorship Agreement and (2) Creative Commons Attributions License.  Please photocopy this document and distribute to co-authors for their original ink signatures.  Please include them with the manuscript submission.

(1)  Authorship & Contributorship Agreement:  In accordance with the Authorship and Contributorship policy of SAUDI MEDICAL JOURNAL, I/We, the undersigned, certify that we have participated in the conception and design of this work, the analysis of the data, the writing of the manuscript, and that we take full responsibility for it.

Corresponding Author:  If I am listed as corresponding author, I agree to provide all authors with information regarding this manuscript and I will obtain their approval before submitting any revision.

Originality of Work:  The undersigned authors state that the article is original, is not under consideration by another Journal, and has not been previously published.

      (2)  Publishing license: I/We, the undersigned, agree to the following terms:

•        Saudi Medical Journal is an Open Access Journal, and articles published are distributed under the terms of the Creative Commons Attribution-Non Commercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. However, the journal retains the right to exploit subsidiary rights on behalf of the authors.
•        Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under the Creative Commons Attribution-Non Commercial License (CC BY-NC). This allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
•        Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
•        Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process with full disclosure to the journal, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Following publication in Saudi Medical Journal, the author should update the repository, and include a citation and link to the published work.


PRINTED NAME        CONTRIBUTION        SIGNATURE        DATE

Corresponding Author:       
       
       

______________________        __________________________        _____________        _______
______________________        __________________________        _____________        _______
______________________        __________________________        _____________        _______
______________________        __________________________        _____________        _______
______________________        __________________________        _____________        _______
______________________        __________________________        _____________        _______
______________________        __________________________        _____________        _______
______________________        __________________________        _____________        _______
______________________        __________________________        _____________        _______
______________________        __________________________        _____________        _______


本人做的关于细胞方面的实验。不知道这个表格中,通讯作者、作者的贡献该怎么填合理,求高手指点。不胜感激
回复此楼
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

paperhunter

荣誉版主 (文学泰斗)

还没想好

优秀版主优秀版主优秀版主优秀版主优秀版主优秀版主优秀版主

【答案】应助回帖

感谢参与,应助指数 +1
...通讯作者、作者的贡献该怎么填合理,

貌似大致分配一下,那几个人是实验完成人,谁负责数据的收集和整理,谁负责论文的写作等等。
咱也是有组织的人了...
4楼2013-02-22 13:24:47
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
查看全部 7 个回答

guoyanfei

金虫 (小有名气)

【答案】应助回帖

感谢参与,应助指数 +1
按你的论文研究内容分配一下就可以了,没有什么合理不合理的,其实杂志是变相的让你申明作者之间没有利益关系
2楼2013-02-22 13:01:52
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

nono2009

超级版主 (文学泰斗)

No gains, no pains.

优秀区长优秀区长优秀区长优秀区长优秀版主

【答案】应助回帖

感谢参与,应助指数 +1
这个表格中,通讯作者、作者的贡献大概填一下即可,例如有人负责实验,有人负责数据分析,有人负责写论文,等等
3楼2013-02-22 13:05:39
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

11jxli1

禁虫 (著名写手)

感谢参与,应助指数 +1
本帖内容被屏蔽

5楼2013-02-22 14:02:17
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
最具人气热帖推荐 [查看全部] 作者 回/看 最后发表
[基金申请] FileCode能看出啥? +7 要乐观耀哥 2026-08-10 17/850 2026-08-11 10:50 by 要乐观耀哥
[基金申请] 奇怪,两个人的filecode固定段从头到尾一模一样 +5 布布和一二 2026-08-10 6/300 2026-08-11 10:15 by 医学老男孩
[基金申请] 我的国基提前知道中了,可是同事的操作让我实在接受不了,怎么会有这样的人 +8 家与远方 2026-08-10 13/650 2026-08-11 09:49 by 家与远方
[基金申请] 小木虫上这么多卖论文的,真有人买论文么?感觉没必要啊 +6 Tide man 2026-08-10 6/300 2026-08-11 09:45 by tangmnt
[基金申请] 为什么网上很多人说本周 12号出结果 +5 瞬息宇宙 2026-08-10 5/250 2026-08-11 09:29 by 铁帽子农民
[基金申请] 帮忙看看fileCode +6 wwncly 2026-08-10 11/550 2026-08-11 09:14 by xiaruohan
[基金申请] 基金中了 +15 laoda193707 2026-08-06 15/750 2026-08-11 00:11 by jiafei2190
[基金申请] 综述论文作为代表作会不会影响评审专家的印象分? +10 yufeiwaner 2026-08-09 11/550 2026-08-10 18:47 by yufeiwaner
[基金申请] 关于代码变化问题,想知道的进来 +17 且听虎啸 2026-08-07 24/1200 2026-08-10 18:35 by zhangduo2008
[基金申请] 静等基金结果 +5 gjjjzhong 2026-08-10 16/800 2026-08-10 17:19 by Tide man
[基金申请] 8月时间戳变的,举个手。玩一下,释放压力 +11 archvillain 2026-08-04 13/650 2026-08-10 14:41 by seekfind
[基金申请] 2026国自然放榜时间 +9 布布和一二 2026-08-08 9/450 2026-08-10 11:22 by xxxx2020
[基金申请] 这样的filecode谁见过 +11 布布和一二 2026-08-08 22/1100 2026-08-10 11:10 by wmfsnow
[基金申请] 面上项目filecode邪修 +5 西山十月 2026-08-09 7/350 2026-08-10 07:32 by 仁砚薪传
[基金申请] fileCode有新解读? +10 Tide man 2026-08-08 18/900 2026-08-09 12:55 by 仁砚薪传
[基金申请] 关于豆爷回答的JTJC与%2F数量 +5 yang182083 2026-08-06 7/350 2026-08-08 18:29 by zhanghaozhu
[基金申请] 国基金的申报应该改成非等额制,评价高的钱多评价低的钱少,但是增加资助率 +7 a089 2026-08-07 7/350 2026-08-08 18:05 by gltch
[基金申请] filecode变化情况 +6 布布和一二 2026-08-07 22/1100 2026-08-07 14:45 by 且听虎啸
[基金申请] 大家散了吧,后缀研究没有意义,别浪费时间了,过好目前的每一天,不要焦虑 +5 Tide man 2026-08-06 7/350 2026-08-07 13:11 by 医学老男孩
[基金申请] 影响面上的因素 +8 布布和一二 2026-08-05 11/550 2026-08-06 10:41 by 宝贝虫子
信息提示
请填处理意见